BioSpace News Archive

Biotech Bay

Sangamo Therapeutics, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

The Compensation Committee of the Company’s Board of Directors has approved the grant effective on February 28, 2018 of inducement stock options to purchase 200,000 shares of common stock to Heather D. Turner, J.D., Senior Vice President and General Counsel.

March 2, 2018
·
1 min read
Genetown

Verastem Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Today announced the grant of stock options to eight new employees to purchase an aggregate of 114,000 shares of Verastem’s common stock.

March 2, 2018
·
2 min read
Deals

Aimmune Therapeutics Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock

Underwritten public offering of 5,500,000 shares of its common stock at a price to the public of $32.00 per share have exercised in full their option to purchase an additional 825,000 shares of common stock at the public offering price, less underwriting discounts and commissions

March 2, 2018
·
2 min read
Policy

IOVANCE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Iovance Biotherapeutics, Inc. - IOVA

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq. announces that KSF has commenced an investigation into Iovance Biotherapeutics, Inc.

March 2, 2018
·
2 min read
Policy

CIVITAS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Civitas Solutions, Inc. - CIVI

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC, announces that KSF has commenced an investigation into Civitas Solutions, Inc. (NYSE: CIVI).

March 2, 2018
·
1 min read